Rank | Regulator | PPI degree | Transcr. degree | Combined score S | Annotation |
---|---|---|---|---|---|
1 | TCF4 | 132 | 41 | 8.5 | Â |
2 | TCF12 | 29 | 43 | 11 | Sanger cancer gene |
3 | TFCP2 | 47 | 32 | 16.5 | Oncogene in hepatocellular carcinoma (HCC); enhances angiogenesis and chemoresistance [39, 40] |
4 | ZBTB7B | 12 | 43 | 17.5 | Â |
5 | SP4 | 11 | 46 | 17.75 | Â |
6 | IKZF1 | 57 | 28 | 19.25 | Sanger cancer gene |
7 | MYOG | 11 | 42 | 21.5 | Â |
8 | SMAD3 | 8 | 34 | 31.5 | |
9 | BCL6B | 14 | 20 | 32.75 | |
10 | WT1 | 3 | 43 | 39.5 | Sanger cancer gene |
11 | LMO2 | 66 | 12 | 40.25 | Sanger cancer gene |
12 | SP2 | 3 | 36 | 45.5 | Â |
13 | CREB5 | 35 | 11 | 48.25 | Â |
14 | TCF3 | 2 | 51 | 48.5 | Sanger cancer gene |
15 | MXI1 | 11 | 13 | 49.5 | Potential tumor suppressor in neuroblastoma and renal cancer [47, 48] |
16 | NRF1 | 4 | 20 | 50.5 | Â |
17 | CREB3L1 | 16 | 11 | 52 | Sanger cancer gene |
18 | USF1 | 5 | 15 | 54.5 | Â |
19 | GABPB1 | 10 | 12 | 56 | Â |
20 | NHLH1 | 2 | 38 | 56.25 | Â |
21 | MAX | 3 | 20 | 57.25 | Sanger cancer gene |
22 | NR1H3 | 3 | 17 | 61.75 | Â |
23 | USF2 | 3 | 15 | 65 | Â |
24 | SMAD4 | 2 | 20 | 69.25 | Sanger cancer gene |
25 | STRA13 | 2 | 20 | 69.25 | Â |
26 | NR1H2 | 2 | 18 | 72 | Â |
27 | EBF1 | 2 | 15 | 77 | Sanger cancer gene |
28 | TFAP4 | 3 | 9 | 82.5 | Linked to non-small cell lung cancer and colorectal cancer [50–52] |
29 | RXRB | 2 | 12 | 85.25 | Â |
30 | NFE2L2 | 2 | 12 | 85.25 | Sanger cancer gene |